Samsrita Labs has scheduled an EGM for October 26, 2026, to seek approval for material related party transactions, including Rs 25 crore in pet care product sales and Rs 1 crore in CCPS investments with S Labs Hygiene Care. Additionally, the company is seeking approval for an unsecured loan of up to Rs 1 crore from its director, Mr. Ravikanth Naga Pattabhi Chopperla. These transactions are significant, given the company's FY 2025-26 annual turnover of Rs 1.81 lakhs.
Samsrita Labs EGM: Material Related Party Transactions Proposed
- Proposed transactions total Rs 26 crore in value.
- FY 2025-26 annual consolidated turnover was Rs 1.81 lakhs.
Reader Takeaway: Shareholders must weigh the massive jump in proposed transaction scale against the company's very small historical turnover base.
What just happened
Samsrita Labs Limited has scheduled its 1st Extraordinary General Meeting (EGM) for the 2026-27 financial year on October 26, 2026. The meeting will be held via video conferencing. Shareholders are being asked to vote on three material related party transactions involving S Labs Hygiene Care Private Limited and the company’s non-executive director, Mr. Ravikanth Naga Pattabhi Chopperla.
The Proposed Transactions
- Sales Agreement: The company proposes to sell pet care-related goods to S Labs Hygiene Care for up to Rs 25 crore between October 2026 and October 2027.
- Strategic Investment: The company intends to subscribe to Compulsorily Convertible Preference Shares (CCPS) of S Labs Hygiene Care for up to Rs 1 crore, utilizing funds from a 2025 preferential issue.
- Director Loan: The board seeks approval to borrow up to Rs 1 crore in unsecured loans from Mr. Ravikanth Naga Pattabhi Chopperla at an interest rate of 9% per annum.
Why this matters
The company has classified these as 'Material Related Party Transactions' because the aggregate value significantly exceeds 10% of its annual consolidated turnover. While management states these are conducted at arm's length to optimize growth, the proposed Rs 25 crore sales target is exponentially higher than the Rs 1.81 lakh turnover reported for FY 2025-26. This indicates a drastic shift in the company's operational scale and business model.
Risks to watch
Investors should monitor the governance implications of the director's 80% stake in the counterparty, S Labs Hygiene Care. The disparity between previous turnover figures and these proposed high-value contracts warrants close scrutiny during the upcoming e-voting process, which concludes on October 19, 2026.